This positive ruling for hygiene brands is a reminder that applicants must be cautious in adopting parts of registered marks, particularly if the identical part is at the beginning, as only differing the end-syllable is not a guarantee of preventing infringement.
The ASCI’s Annual Complaints Report 2023-2024 reveals crucial insights into brand advertising campaigns in India, with 98% of scrutinised ads requiring modification. Misleading ads present a challenge for law enforcement and brands must adhere to court rulings or else risk the suspension of their manufacturing licences.
In our latest round-up, we look at the adidas motion for a new Thom Browne trial being denied, an OtterBox counterfeit bust, and more.
Delhi High Court holds that Maersk Pharma's trademark has a high likelihood of confusion, and infringes on Maersk’s established goodwill and worldwide recognition.
25 July 2024
Apple was the standout stock market performer through May, with technology brands posting strong results.
02 July 2024
The decision sets forth some criteria to determine whether goods or services should be considered the same or equivalent.
25 June 2024
Even though the applicants were the first to extract and exploit IP-PA1, it did not necessarily follow that they should obtain trademark protection over the term.
21 June 2024
The decision highlights the importance of considering implied – as well as express – comparisons when deploying comparative advertising.
14 June 2024
These decisions are the first by national courts to interpret the CJEU’s preliminary ruling in Joined Cases C‑253/20 and C‑254/20.
13 June 2024
The input from trademark practitioners in this survey form is essential to capture an accurate representation of the current IP environment around the world.
03 June 2024
The burden of proving trademark infringement is lighter in cases involving medicinal drugs - especially Schedule-H drugs, which can be sold only by medical prescription.
03 June 2024
The court found that the defendants’ use of the mark VIGOURA in relation to homeopathic medicine amounted to infringement and passing off of Pfizer’s registered mark VIAGRA.
30 May 2024
Unlock unlimited access to all WTR content
